Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04055220
Title Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (REGOSTA)
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Centre Leon Berard
Indications

osteosarcoma

bone sarcoma

Therapies

Regorafenib

Age Groups: adult | child | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Hôpital Jean Minjoz Not yet recruiting Besançon 25000 France Details
Institut Bergonié Not yet recruiting Bordeaux 33076 France Details
Centre Oscar Lambret Not yet recruiting Lille 59020 France Details
Centre Léon Bérard Recruiting Lyon 69373 France Details
APHM - Hôpital Timone Not yet recruiting Marseille 13385 France Details
ICM Val d'Aurelle Not yet recruiting Montpellier 34298 France Details
Institut Curie Recruiting Paris 75005 France Details
APHP Hôpital Cochin Recruiting Paris 75014 France Details
Centre Hospitalier Universitaire de Poitiers Not yet recruiting Poitiers 86000 France Details
ICO René Gauducheau Recruiting Saint-Herblain 44805 France Details
Centre Hospitalier Universitaire de Saint-Etienne (CHUSE) Recruiting Saint-Étienne 42055 France Details
Institut de Cancérologie Strasbourg Europe Not yet recruiting Strasbourg 67033 France Details
Centre Hospitalier Régional de Strasbourg Hautepierre Not yet recruiting Strasbourg 67098 France Details
IUCT-Oncopole Not yet recruiting Toulouse 31059 France Details
ICL Alexis Vautrin Not yet recruiting Vandœuvre-lès-Nancy 54519 France Details
Institut Gustave Roussy Not yet recruiting Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field